60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Gross Profit Margin (Quarterly) : 27.32% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.32% |
| March 31, 2026 | 47.13% |
| December 31, 2025 | 61.85% |
| September 30, 2025 | -1.72% |
| June 30, 2025 | 83.73% |
| March 31, 2025 | 71.40% |
| December 31, 2024 | 56.65% |
| September 30, 2024 | 24.58% |
| June 30, 2024 | 28.72% |
| Date | Value |
|---|---|
| March 31, 2024 | 51.66% |
| December 31, 2023 | -242.6% |
| September 30, 2023 | 43.85% |
| June 30, 2023 | -193.8% |
| March 31, 2023 | -240.5% |
| September 30, 2022 | 71.04% |
| March 31, 2022 | 45.07% |
| December 31, 2021 | 75.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Harrow, Inc. | 71.27% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -233.6% |
| Return on Assets | -148.3% |
| Return on Invested Capital | -223.7% |
| Profit Margin (Quarterly) | -1.09K% |
| Operating Margin (Quarterly) | -1.09K% |
| Return on Net Operating Assets | -482.6% |